IP Library Granted Patent US 7,629,116
Granted Patent B2
US 7,629,116 · App. 10/441,418 · Granted Dec 8, 2009

Type I interferon-inducible proteins to detect viral infection

Assignee: Idaho Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,629,116
App. No.
10/441,418
Granted
Dec 8, 2009
Kind
B2
Abstract

A method for determining the presence of a viral infection in an animal not known to have been infected with a virus or other disease-causing microbial organism by determining the level of Mx protein or other Type I Interferon-inducible protein in the animal.

Claims (15)

1. A method for screening an animal for being an asymptomatic carrier of a viral infection associated with increased expression of Mx protein comprising determining the level of expression of Mx protein in a first animal not known to have been infected with a virus or other disease-causing microbial organism and not showing any clinical signs consistent with a viral infection, and comparing the level of expression of said protein in the animal to that of a second animal of the same species known to be free of viral infection, and determining the first animal to be viral-infection positive if the level of expression of Mx protein in the first animal is significantly elevated compared to the level of expression of Mx protein in the second animal.

2. The method of claim 1 wherein the first animal is a mammal.

3. The method of claim 2 wherein the mammal is a member of the order perissodactyla or artiodactyla.

4. The method of claim 3 wherein the mammal is selected from the group consisting of cattle, sheep, goats, horses, swine, and llamas.

5. The method of claim 2 wherein the mammal is a member of the order carnivora.

6. The method of claim 5 wherein the mammal is a member of the family of canidae or felidae.

7. The method of claim 2 wherein the mammal is a primate.

8. The method of claim 7 wherein the primate is a human.

9. The method of claim 1 wherein the level of expression of Mx protein is determined by determining the level of mRNA coding for Mx protein.

10. The method of claim 9 wherein the determination of mRNA is by Northern blot analysis, slot-blot analysis, or polymerase chain reaction.

11. The method of claim 1 wherein the level of expression of Mx protein is determined by determining the level of Mx protein.

12. The method of claim 11 wherein the determination of the level of Mx protein is by evaluating the binding of an antibody to the protein or by an assay based on a function of the protein.

13. The method of claim 12 wherein the level of Mx protein is detected by a colorimetric assay.

14. The method of claim 1 wherein the level of expression of the protein is determined by determining the expression of the protein in a cell of the animal.

15. The method of claim 1 wherein the level of expression of the protein is determined by analyzing a bodily fluid of the animal.

Assignments (2)
CONFIRMATORY LICENSE Recorded Mar 24, 2010
From: UNIVERSITY OF IDAHO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024128/0055 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2003
From: OTT, TROY L.
To: IDAHO RESEARCH FOUNDATION
Reel/Frame 014100/0349 →
Continuity (1)
Related Publication 20040009472A1 · Jan 15, 2004